CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans.
View Top Employees from CellProthera SASWebsite | https://www.cellprothera.com |
Revenue | $6.9 million |
Employees | 33 (27 on RocketReach) |
Founded | 2008 |
Address | 12 Rue Du Parc, Mulhouse, Grand Est 68100, FR |
Phone | +33 3 69 71 97 71 |
Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Medical |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular CellProthera SAS employee's phone or email?
The CellProthera SAS annual revenue was $6.9 million in 2024.
Ibon Garitaonandia is the Chief Scientific Officer of CellProthera SAS.
27 people are employed at CellProthera SAS.
CellProthera SAS is based in Mulhouse, Grand Est.
The NAICS codes for CellProthera SAS are [541713, 541, 5417, 54, 54171].
The SIC codes for CellProthera SAS are [87, 873].